• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

奥密克戎变异株出现后纽约州接种疫苗和未接种疫苗的儿童及青少年的感染和住院风险

Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.

作者信息

Dorabawila Vajeera, Hoefer Dina, Bauer Ursula E, Bassett Mary T, Lutterloh Emily, Rosenberg Eli S

机构信息

New York State Department of Health, Albany.

出版信息

JAMA. 2022 Jun 14;327(22):2242-2244. doi: 10.1001/jama.2022.7319.

DOI:10.1001/jama.2022.7319
PMID:35559959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9107062/
Abstract

This database study examines vaccination for COVID-19 among children in New York after the emergence of the Omicron variant, including analysis of case rates and hospitalizations for COVID-19 disease.

摘要

这项数据库研究调查了奥密克戎变种出现后纽约儿童的新冠疫苗接种情况，包括对新冠病例率和住院情况的分析。

相似文献

1
Risk of Infection and Hospitalization Among Vaccinated and Unvaccinated Children and Adolescents in New York After the Emergence of the Omicron Variant.奥密克戎变异株出现后纽约州接种疫苗和未接种疫苗的儿童及青少年的感染和住院风险
JAMA. 2022 Jun 14;327(22):2242-2244. doi: 10.1001/jama.2022.7319.
2
COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.COVID-19 病例和住院情况按 COVID-19 疫苗接种状况和既往 COVID-19 诊断情况划分-加利福尼亚州和纽约州，2021 年 5 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):125-131. doi: 10.15585/mmwr.mm7104e1.
3
Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant.新冠病毒奥密克戎变异株出现后纽约儿童和青少年的感染及住院风险
JAMA. 2022 Oct 11;328(14):1460. doi: 10.1001/jama.2022.14481.
4
Risk of Infection and Hospitalization Among Children and Adolescents in New York After Emergence of the SARS-CoV-2 Omicron Variant-Reply.SARS-CoV-2奥密克戎变异株出现后纽约儿童和青少年的感染及住院风险-回复
JAMA. 2022 Oct 11;328(14):1460-1461. doi: 10.1001/jama.2022.14484.
5
Omicron BA.1/1.1 SARS-CoV-2 Infection among Vaccinated Canadian Adults.加拿大接种疫苗的成年人中的奥密克戎BA.1/1.1型严重急性呼吸综合征冠状病毒2感染
N Engl J Med. 2022 Jun 16;386(24):2337-2339. doi: 10.1056/NEJMc2202879. Epub 2022 May 18.
6
SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.2021 年 5 月 1 日至 7 月 25 日，加利福尼亚州洛杉矶县≥16 岁人群中，根据疫苗接种状况划分的 SARS-CoV-2 感染和住院情况。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1170-1176. doi: 10.15585/mmwr.mm7034e5.
7
Association of Prior BNT162b2 COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection in Children and Adolescents During Omicron Predominance.在奥密克戎毒株占主导期间，既往BNT162b2型新冠疫苗接种与儿童及青少年有症状的新冠病毒感染之间的关联
JAMA. 2022 Jun 14;327(22):2210-2219. doi: 10.1001/jama.2022.7493.
8
Transmission of and Infection With COVID-19 Among Vaccinated and Unvaccinated Attendees of an Indoor Wedding Reception in Minnesota.明尼苏达州室内婚礼接待会上，接种疫苗和未接种疫苗的与会者之间 COVID-19 的传播和感染。
JAMA Netw Open. 2022 Feb 1;5(2):e220536. doi: 10.1001/jamanetworkopen.2022.0536.
9
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.mRNA COVID-19 疫苗 3 剂接种与 SARS-CoV-2 奥密克戎和德尔塔变异株引起的有症状感染之间的关联。
JAMA. 2022 Feb 15;327(7):639-651. doi: 10.1001/jama.2022.0470.
10
COVID-19 Vaccination and Hospitalization Among Persons Living With Diagnosed HIV in New York State.纽约州确诊 HIV 感染者的 COVID-19 疫苗接种和住院情况。
J Acquir Immune Defic Syndr. 2023 Jun 1;93(2):92-100. doi: 10.1097/QAI.0000000000003177. Epub 2023 Feb 21.

引用本文的文献

1
Leveraging Multiple Administrative Data Sources to Reduce Missing Race and Ethnicity Data: A Descriptive Epidemiology Cross-Sectional Study of COVID-19 Case Relative Rates.利用多个行政数据源减少种族和族裔数据缺失：一项关于COVID-19病例相对率的描述性流行病学横断面研究。
J Racial Ethn Health Disparities. 2024 Oct 22. doi: 10.1007/s40615-024-02211-w.
2
Omicron variant infection worsen the prognosis of haemodialysis (HD) patients.奥密克戎变异株感染使血液透析（HD）患者的预后恶化。
Ann Med. 2024 Dec;56(1):2394582. doi: 10.1080/07853890.2024.2394582. Epub 2024 Aug 25.
3
Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China.中国儿童和青少年接种新冠灭活疫苗后感染奥密克戎BA.5的传播风险
Commun Med (Lond). 2024 May 18;4(1):92. doi: 10.1038/s43856-024-00521-y.
4
Effectiveness of BNT162b2 COVID-19 primary series vaccination in children aged 5-17 years in the United States: a cohort study.辉瑞-BioNTech COVID-19 疫苗对美国 5-17 岁儿童初级系列接种的有效性：一项队列研究。
BMC Pediatr. 2024 Apr 26;24(1):276. doi: 10.1186/s12887-024-04756-5.
5
The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis.新冠病毒疫苗对儿童和青少年奥密克戎变异株的影响：一项系统评价和荟萃分析。
Front Public Health. 2024 Apr 10;12:1338208. doi: 10.3389/fpubh.2024.1338208. eCollection 2024.
6
Critically ill children with SARS-COV-2 Omicron infection at a national children medical center, Guangdong, China.中国广东国家儿童医学中心收治的 SARS-COV-2 奥密克戎感染危重症儿童。
BMC Pediatr. 2024 Apr 15;24(1):254. doi: 10.1186/s12887-024-04735-w.
7
Contact tracing: Characteristics of COVID-19 cases that provided contacts.接触者追踪：提供接触者的 COVID-19 病例特征。
PLoS One. 2023 Nov 2;18(11):e0293208. doi: 10.1371/journal.pone.0293208. eCollection 2023.
8
Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period.应用寿命表方法评估奥密克戎变异期间使用 COVID-19 病例监测数据按年龄划分的 BNT162b2 疫苗衍生免疫的持续时间。
PLoS One. 2023 Sep 20;18(9):e0291678. doi: 10.1371/journal.pone.0291678. eCollection 2023.
9
Clinical characteristics of abruptly increased paediatric patients with Omicron BF.7 or BA.5.2 in Beijing.北京 Omicron BF.7 或 BA.5.2 亚株感染儿童患者突然增多的临床特征。
Virol J. 2023 Sep 8;20(1):209. doi: 10.1186/s12985-023-02177-x.
10
Adolescent COVID-19 Cases During the SARS-CoV-2 Delta and Omicron Variant Surges in Kentucky: Association With Vaccination and Prior Infection.肯塔基州 SARS-CoV-2 德尔塔和奥密克戎变异株流行期间的青少年 COVID-19 病例：与疫苗接种和既往感染的关系。
J Adolesc Health. 2023 Sep;73(3):536-542. doi: 10.1016/j.jadohealth.2023.04.032. Epub 2023 May 12.

本文引用的文献

1
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022.2 剂 BNT162b2（辉瑞-生物科技）mRNA 疫苗预防 5-11 岁儿童和 12-15 岁青少年感染 SARS-CoV-2 的效果 - PROTECT 队列，2021 年 7 月至 2022 年 2 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 18;71(11):422-428. doi: 10.15585/mmwr.mm7111e1.
2
Covid-19 Vaccine Effectiveness in New York State.纽约州的新冠疫苗有效性。
N Engl J Med. 2022 Jan 13;386(2):116-127. doi: 10.1056/NEJMoa2116063. Epub 2021 Dec 1.
3
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.5至11岁儿童中BNT162b2新冠疫苗的评估
N Engl J Med. 2022 Jan 6;386(1):35-46. doi: 10.1056/NEJMoa2116298. Epub 2021 Nov 9.
4
Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents.BNT162b2疫苗对青少年Delta变异株的有效性
N Engl J Med. 2021 Nov 25;385(22):2101-2103. doi: 10.1056/NEJMc2114290. Epub 2021 Oct 20.
5
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents.辉瑞-BioNTech 新冠疫苗在青少年中的安全性、免疫原性和有效性。
N Engl J Med. 2021 Jul 15;385(3):239-250. doi: 10.1056/NEJMoa2107456. Epub 2021 May 27.